Chimera Partners

Shoplazza is a shopping cart commerce technology company established in 2017, focused on providing an all-in-one eCommerce platform for businesses of all sizes. The platform enables merchants to easily start, market, and manage their online stores through a single integrated back-end system. It emphasizes reliability, security, and adaptability, allowing merchants to create a headless commerce experience. Shoplazza also has a North America-based Direct-to-Customer branding incubation team that supports merchants in building memorable and distinctive brands while fostering direct relationships with buyers. The company's advanced data analytical capabilities enhance its offerings, ensuring that merchants can effectively grow their businesses independently. With its global strategy department located in Toronto, Shoplazza aims to empower merchants worldwide.

CMR Surgical Limited, based in Cambridge, United Kingdom, specializes in the design and manufacture of medical devices tailored for minimal access surgery. The company is recognized for its Versius surgical robotic system, which enhances laparoscopic surgical procedures by making them more accessible and affordable. Founded in 2014 and originally named Cambridge Medical Robotics, CMR Surgical aims to expand the capabilities of robotic surgery, allowing a broader range of procedures to be performed. The system provides surgeons with 3D high-definition imagery and real-time feedback, significantly improving the surgical experience and outcomes for patients.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

GoReport is a Belfast-based company that specializes in survey management solutions for the property sector. Founded in 2011, it offers a platform that allows surveyors to conduct various types of surveys and generate reports more efficiently. The platform enables users to capture relevant survey data directly on an iPad through an intuitive interface that includes standard and custom phrases, automated voice-to-text capabilities, and pick lists. By streamlining the reporting process, GoReport significantly reduces the time required to complete surveys and create branded reports, helping businesses enhance their operational efficiency.

Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

Fuel3D is a developer of advanced 3D imaging technology that offers a handheld 3D scanning system capable of capturing high-resolution shape and color information. Initially created for the medical imaging sector at Oxford University, this point-and-shoot scanner is designed to facilitate the rapid generation of 3D images for diverse applications, including art, animation, and game development. The innovative technology combines pre-calibrated stereo cameras with photometric imaging, allowing users to quickly and affordably produce detailed 3D representations, which are typically expensive and time-consuming to create. Fuel3D aims to make high-quality 3D scanning accessible to a broader audience, including independent developers and artists. The company is led by CEO Stuart Mead, who has extensive experience in global technology ventures, and continues to adapt its technology for various markets beyond its original medical focus.